Drug Type Gene therapy |
Synonyms- |
Target- |
Action- |
Mechanism Gene transference |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 1 | United States | 07 Feb 2022 | |
Mild cognitive disorder | Phase 1 | United States | 07 Feb 2022 | |
Parkinson Disease | Discovery | United States | 01 Mar 2021 |
Phase 2 | - | qmksqkwsph(hiygaskblg) = epizurlilj bckncgjena (usmjnfvfcy ) View more | Positive | 28 Apr 2020 | |||
venrhgxusp(fgmbqkxzfm) = mbjzuyjdfi gmbjpgvwfq (iocioqminn ) |